Explore verification

Current Runner → Verification path commissioned end to end

Milestone occurred: 6 September 2026
Public milestone record published: 11 September 2026

What happened

The current production Assurance Runner → Verification publication path completed its first end-to-end external commissioning against IBANforge IBAN Validate.

Two bounded x402 calls were made—one positive and one negative checksum control—at 0.005 USDC each. Atinamos independently calculated the expected ISO 13616 MOD-97 result, observed Base settlement, captured fulfilment, compared only the returned valid field against the independent expectation and published two signed Evidence Receipts.

Both controls matched their expected result.

Why it mattered

Earlier work had proved individual pieces: buying, settlement observation, objective assertions, signed receipts and autonomous selection. This commissioning joined the current production Runner and current Verification publication path in one bounded external experiment.

It was also explicit about scope: correctness of valid was independently checked; unrelated BIC, SEPA, bank or enrichment fields were not.

What it proved

The commissioning supports that the current production path could perform:

controlled test definition
→ bounded x402 purchase
→ independent Base settlement observation
→ fulfilment capture
→ deterministic correctness comparison
→ immutable Verification package
→ signed Evidence Receipt publication
→ public buyer lookup

What it did not prove

This run was human-triggered commissioning using Runner-controlled execution logic. It was not unattended production autonomy.

It also did not prove provider-wide IBAN correctness or permanent reliability.

Primary record

External Assurance Runner commissioning — IBANforge contains the control values, settlement references and signed receipt links.

Capability transition

production components exist
→ one bounded external commissioning
→ payment + settlement + correctness + signed publication joined end to end

← Previous milestone · Next milestone: unattended generic Assurance →